Meridian Medical Technologies Inc
- View government funding actions
- Columbia, MD 21046
- Phone: 443-259-7872
- Estimated Number of Employees: 110,600
- Estimated Annual Receipts: $68,000,000,000
- Business Start Date: 1996
- Contact Person: Paul Muma
- Contact Phone: 443-259-7846
- Contact Email: Paul.Muma@meridianmt.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- For Profit Organization
- Manufacturer of Goods
- Industries Served: Pharmaceutical Preparation Manufacturing, Surgical and Medical Instrument Manufacturing
- Product Areas: DRUGS AND BIOLOGICALS
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $6,498,000 - Wednesday the 10th of September 2014
Defense Logistics Agency
DLA TROOP SUPPORT
4522513207!ANTIDOTE TREATMENT - $6,198,000 - Thursday the 20th of February 2014
Defense Logistics Agency
DLA TROOP SUPPORT
4519381765!ANTIDOTE TREATMENT - $57,586 - Tuesday the 21st of August 2012
Federal Bureau Of Investigation
DEPT OF JUST/FEDERAL BUREAU OF INVESTIGATION
MEDICAL INJECTORS - $57 - Thursday the 2nd of February 2012
Defense Logistics Agency
DLA TROOP SUPPORT
4519991567!TRAINING AID,MORPHI - $3,715 - Thursday the 27th of July 2017
Office Of Assistant Secretary For Administration
PHA CO, PHS, SSC, PERRY POINT MD
CRITICAL FUNCTIONS: MEDICAL SUPPLIES FOR MAIN - $27,346 - Thursday the 29th of December 2011
Defense Logistics Agency
DLA TROOP SUPPORT
4519991567!TRAINING AID,MORPHI - $1,834,605 - Tuesday the 28th of February 2012
Department Of Army
W6QK ACC-RSA
DEVELOPMENT AND DELIVERY OF FDA APPROVED - $15,790 - Monday the 18th of April 2016
Office Of Assistant Secretary For Administration
PHA CO, PHS, SSC, PERRY POINT MD
FDAE DUODOTE AUTO INJECTOR 30S - $155,120 - Thursday the 20th of February 2014
Defense Logistics Agency
DLA TROOP SUPPORT
4520411331!MORPHINE - $1,533,750 - Thursday the 20th of February 2014
Defense Logistics Agency
DLA TROOP SUPPORT
4521240987!DIAZEPAM INJECTION,
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.